Skip to main content

Geisinger nurse to tell powerful personal story of how epidemic affected her family

DANVILLE, Pa. – Geisinger is joining other national health care leaders to develop innovative ways that technology and data can be used to address the nationwide opioid epidemic. The latest innovations will be the subject of an Opioid Symposium and Code-a-Thon hosted by the U.S. Department of Health & Human Services in Washington, D.C. The symposium will be held on December 6-7.

A Geisinger post-anesthesia care unit (PACU) nurse, who lost her 23-year-old daughter to heroin addiction, will also speak at the event to share her powerful personal story.

Bridget Farrell’s daughter Delaney died from an overdose this past summer. Before her death, Delaney wrote an emotional poem about her addiction. Bridget decided to include the poem in her daughter’s obituary which received attention all over the country. “I want people to understand the struggle of Delaney and our family,” said Bridget. “Most importantly, I want them to see who she was. This beautiful, vibrant girl.”

Since 2014, Geisinger has reduced opioid prescriptions in emergency departments, physician offices and community practice clinics by almost half, from an average of 60,000 prescriptions per month to 31,000. The dramatic decrease in prescribing opioids is the result of the health system’s proactive team approach to managing chronic pain and using several different treatment options to address patients who are addicted to opioids or may be at-risk for addiction. 

“At Geisinger, we wage the battle on multiple fronts every day,” said Dr. David T. Feinberg, M.D., Geisinger President and CEO. “We’ve worked to combat this epidemic for many years, and we’ll continue to study, innovate and share our results with other communities until we can all declare victory over this crisis.”


About Geisinger
One of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. Geisinger is known for its focus on caring and innovative programs including the ProvenCare® best-practice approach to maximize quality, safety and value; ProvenHealth Navigator® advanced medical home; Springboard Health® population health program to improve the health of an entire community; ProvenExperience™ to provide refunds to patients unhappy with their care experience; and Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world. With more than 215,000 volunteer participants enrolled, MyCode is conducting extensive research and returning medically actionable results to participants. A physician-led organization, with approximately 32,000 employees and more than 1,800 employed physicians, Geisinger leverages an estimated $12.7 billion positive annual impact on the Pennsylvania and New Jersey economies. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service. For more information, visit, or connect with us on Facebook, Instagram, LinkedIn and Twitter.


For media inquiries:

Marc Stempka
Media Specialist
Marketing & Communications